{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:43:20Z","timestamp":1793036600446,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Healthcare of the Republic of Kazakhstan","award":["BR27304987"],"award-info":[{"award-number":["BR27304987"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Popul Health Metrics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Arterial hypertension (AH) is a major contributor to cardiovascular morbidity and mortality worldwide. This study aimed to identify sociodemographic and biological factors associated with hypertension in a nationally representative adult sample in Kazakhstan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional WHO STEPS survey (October 2021\u2013May 2022) included 6,720 adults aged 18\u201369 years from all regions of Kazakhstan. Sociodemographic, behavioral, physical and biochemical data were collected, hypertension was defined by ESC\/ESH criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Crude AH prevalence was 16.0% (95% CI 15.1\u201316.8) and increased sharply with age from 3.0% at 18\u201324 years to 46.7% at \u2265\u200965 years (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Men had higher systolic (SBP) and diastolic blood pressure (DBP) than women (126\/82 vs. 119\/79 mmHg,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and a less favorable BP profile. Urban residents were younger and more likely to report smoking and alcohol use than rural residents (21.4% vs. 14.8% and 6.5% vs. 3.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), whereas rural participants had higher BMI, SBP, DBP, total cholesterol and HbA1c (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Hypertension prevalence showed marked regional heterogeneity, from 9.5% in Kyzylorda and 9.6% in Astana to 25.3% in Akmola and 23.7% in North Kazakhstan. In adjusted models, hypertension was independently associated with older age (OR 1.894, 95% CI 1.780\u20132.014,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), higher BMI (OR 1.597, 95% CI 1.484\u20131.719,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), higher total cholesterol (OR 1.171, 95% CI 1.098\u20131.249,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and urban residence (OR 1.304, 95% CI 1.121\u20131.517,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), while female sex was protective (OR 0.596, 95% CI 0.511\u20130.696,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Smoking, HbA1c, education and ethnicity were not significant after adjustment, and alcohol intake showed a statistically detectable but clinically minimal association (OR 0.997, 95% CI 0.995\u20130.999).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In 2021\u20132022, hypertension affected roughly one in six adults in Kazakhstan and rose steeply with age. Modifiable metabolic factors, particularly excess body weight and elevated cholesterol, were the main drivers of risk, while an independent urban effect and pronounced north\u2013south regional differences highlight the need for targeted weight and lipid management and intensified long-term risk control, especially in cities and high-prevalence northern regions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12963-026-00454-9","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:34:45Z","timestamp":1768412085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Socio-demographic, behavioral, and biological risk factors of hypertension in Kazakhstan: results of a national study"],"prefix":"10.1186","volume":"24","author":[{"given":"Yevgeniy","family":"Zhukov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuanysh","family":"Nikatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermek","family":"Dyussembekov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rauan","family":"Kastey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyazbek","family":"Yerniyazov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukhtar","family":"Korabayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darina","family":"Menlayakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talgat","family":"Muminov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shynar","family":"Tanabayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildar","family":"Fakhradiyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Shoranov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"6","key":"454_CR1","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334\u201357.","journal-title":"Hypertension"},{"issue":"5","key":"454_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00003495-199957050-00003","volume":"57","author":"M Kornitzer","year":"1999","unstructured":"Kornitzer M, Dramaix M, De Backer G. Epidemiology of risk factors for hypertension: implications for prevention and therapy. Drugs. 1999;57(5):695\u2013712.","journal-title":"Drugs"},{"issue":"4","key":"454_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"454_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, et al. Global disparities of hypertension prevalence and control: A systematic analysis of Population-Based studies from 90 countries. Circulation. 2016;134(6):441\u201350.","journal-title":"Circulation"},{"issue":"8","key":"454_CR5","doi-asserted-by":"publisher","first-page":"e0256596","DOI":"10.1371\/journal.pone.0256596","volume":"16","author":"M Costa","year":"2021","unstructured":"Costa M, Caro JJ, Bloch KV. Risk factors in adolescents as predictors of arterial hypertension in adults: protocol for a systematic review. PLoS ONE. 2021;16(8):e0256596.","journal-title":"PLoS ONE"},{"issue":"11","key":"454_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1080\/09603123.2022.2076814","volume":"33","author":"KD Konlan","year":"2023","unstructured":"Konlan KD, et al. Risk factors associated with the incidence and prevalence of hypertension in ghana: an integrated review (2016\u20132021). Int J Environ Health Res. 2023;33(11):1132\u201347.","journal-title":"Int J Environ Health Res"},{"issue":"1","key":"454_CR7","doi-asserted-by":"publisher","first-page":"e24165","DOI":"10.1002\/clc.24165","volume":"47","author":"J Niu","year":"2024","unstructured":"Niu J, et al. Sex-related association of modifiable risk factors with hypertension: A National cross-sectional study of NHANES 2007\u20132018. Clin Cardiol. 2024;47(1):e24165.","journal-title":"Clin Cardiol"},{"key":"454_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/VHRM.S417693","volume":"19","author":"G Junusbekova","year":"2023","unstructured":"Junusbekova G, et al. Recent trends in cardiovascular disease mortality in Kazakhstan. Vasc Health Risk Manag. 2023;19:519\u201326.","journal-title":"Vasc Health Risk Manag"},{"key":"454_CR9","doi-asserted-by":"crossref","unstructured":"Yerdessov S et al. Epidemiology of arterial hypertension in kazakhstan: data from unified nationwide electronic healthcare system 2014\u20132019. J Cardiovasc Dev Dis. 2022;9(2):52.","DOI":"10.3390\/jcdd9020052"},{"issue":"1","key":"454_CR10","doi-asserted-by":"publisher","first-page":"20917","DOI":"10.1038\/s41598-023-47899-8","volume":"13","author":"N Glushkova","year":"2023","unstructured":"Glushkova N, et al. Examining disparities in cardiovascular disease prevention strategies and incidence rates between urban and rural populations: insights from Kazakhstan. Sci Rep. 2023;13(1):20917.","journal-title":"Sci Rep"},{"key":"454_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/VHRM.S199178","volume":"15","author":"S Pengpid","year":"2019","unstructured":"Pengpid S, et al. The prevalence, awareness, treatment, and control of hypertension among adults: the first cross-sectional National population-based survey in Laos. Vasc Health Risk Manag. 2019;15:27\u201333.","journal-title":"Vasc Health Risk Manag"},{"issue":"5","key":"454_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.amjmed.2022.12.015","volume":"136","author":"AK Cheung","year":"2023","unstructured":"Cheung AK, et al. International consensus on standardized clinic blood pressure Measurement - A call to action. Am J Med. 2023;136(5):438\u2013e4451.","journal-title":"Am J Med"},{"issue":"2","key":"454_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jch.14414","volume":"24","author":"S Palomo-Pi\u00f1\u00f3n","year":"2022","unstructured":"Palomo-Pi\u00f1\u00f3n S, et al. Prevalence and characterization of undiagnosed arterial hypertension in the Eastern zone of Mexico. J Clin Hypertens (Greenwich). 2022;24(2):131\u20139.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7","key":"454_CR14","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s11739-023-03376-8","volume":"18","author":"S Romano","year":"2023","unstructured":"Romano S, et al. Hypertension, uncontrolled hypertension and resistant hypertension: prevalence, comorbidities and prescribed medications in 228,406 adults resident in urban areas. A population-based observational study. Intern Emerg Med. 2023;18(7):1951\u20139.","journal-title":"Intern Emerg Med"},{"issue":"9","key":"454_CR15","doi-asserted-by":"publisher","first-page":"e0137408","DOI":"10.1371\/journal.pone.0137408","volume":"10","author":"R Ratovoson","year":"2015","unstructured":"Ratovoson R, et al. Hypertension, a neglected disease in rural and urban areas in Moramanga, Madagascar. PLoS ONE. 2015;10(9):e0137408.","journal-title":"PLoS ONE"},{"key":"454_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2019.01.016","volume":"63","author":"F Angeli","year":"2019","unstructured":"Angeli F, et al. European and US guidelines for arterial hypertension: similarities and differences. Eur J Intern Med. 2019;63:3\u20138.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"454_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4103\/ijmr.IJMR_48_19","volume":"154","author":"MA Ganie","year":"2021","unstructured":"Ganie MA, et al. Prevalence, pattern & correlates of hypertension among tribal population of Kashmir, india: A cross-sectional study. Indian J Med Res. 2021;154(3):467\u201375.","journal-title":"Indian J Med Res"},{"key":"454_CR18","doi-asserted-by":"publisher","first-page":"p9032476","DOI":"10.1155\/2020\/9032476","volume":"2020","author":"AJ Muhihi","year":"2020","unstructured":"Muhihi AJ, et al. Prevalence, Awareness, Treatment, and control of hypertension among young and Middle-Aged adults: results from a Community-Based survey in rural Tanzania. Int J Hypertens. 2020;2020:p9032476.","journal-title":"Int J Hypertens"},{"issue":"7","key":"454_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/CIRCRESAHA.120.318729","volume":"128","author":"AE Schutte","year":"2021","unstructured":"Schutte AE, et al. Hypertension in Low- and Middle-Income countries. Circ Res. 2021;128(7):808\u201326.","journal-title":"Circ Res"},{"key":"454_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2017.05.013","volume":"122","author":"G Seravalle","year":"2017","unstructured":"Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017;122:1\u20137.","journal-title":"Pharmacol Res"},{"issue":"6","key":"454_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall JE, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116(6):991\u20131006.","journal-title":"Circ Res"},{"issue":"3","key":"454_CR22","first-page":"e95","volume":"39","author":"J Poorolajal","year":"2017","unstructured":"Poorolajal J, et al. How much excess weight loss can reduce the risk of hypertension? J Public Health (Oxf). 2017;39(3):e95\u2013102.","journal-title":"J Public Health (Oxf)"},{"issue":"9","key":"454_CR23","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"CK Chow","year":"2013","unstructured":"Chow CK, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959\u201368.","journal-title":"JAMA"},{"issue":"8","key":"454_CR24","doi-asserted-by":"publisher","first-page":"e0256811","DOI":"10.1371\/journal.pone.0256811","volume":"16","author":"HK Segawa","year":"2021","unstructured":"Segawa HK, et al. Gender with marital status, cultural differences, and vulnerability to hypertension: findings from the National survey for noncommunicable disease risk factors and mental health using WHO STEPS in Bhutan. PLoS ONE. 2021;16(8):e0256811.","journal-title":"PLoS ONE"},{"issue":"4","key":"454_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/jhh.2015.92","volume":"30","author":"A Camara","year":"2016","unstructured":"Camara A, et al. High prevalence, low awareness, treatment and control rates of hypertension in guinea: results from a population-based STEPS survey. J Hum Hypertens. 2016;30(4):237\u201344.","journal-title":"J Hum Hypertens"},{"issue":"11","key":"454_CR26","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/clc.23938","volume":"45","author":"BV Silva","year":"2022","unstructured":"Silva BV, et al. Management of arterial hypertension: challenges and opportunities. Clin Cardiol. 2022;45(11):1094\u20139.","journal-title":"Clin Cardiol"},{"key":"454_CR27","doi-asserted-by":"crossref","unstructured":"Guzik A, Bushnell C. Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn), 2017. 23(1, Cerebrovascular Disease): pp. 15\u201339.","DOI":"10.1212\/CON.0000000000000416"},{"issue":"5","key":"454_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1755-5949.2011.00264.x","volume":"17","author":"JG Yu","year":"2011","unstructured":"Yu JG, Zhou RR, Cai GJ. From hypertension to stroke: mechanisms and potential prevention strategies. CNS Neurosci Ther. 2011;17(5):577\u201384.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"454_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1747-4949.2006.00041.x","volume":"1","author":"LS Liu","year":"2006","unstructured":"Liu LS, et al. Reducing stroke risk in hypertensive patients: Asian consensus conference recommendations. Int J Stroke. 2006;1(3):150\u20137.","journal-title":"Int J Stroke"}],"container-title":["Population Health Metrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12963-026-00454-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-026-00454-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-026-00454-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:07:54Z","timestamp":1770649674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12963-026-00454-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1186\/s12963-026-00454-9","relation":{},"ISSN":["1478-7954"],"issn-type":[{"value":"1478-7954","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The S.D. Asfendiyarov Kazakh National Medical University Local Ethics Committee approved the study, as documented in protocol No. 12 (118) dated 28.09.2021). All methods were performed in accordance with the relevant guidelines. Informed consent was obtained from all subjects and for uneducated participants, informed consent was obtained from their guardian\/legally authorized representative.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}